Display options
Cite
Drekonja DM, Johnson JR. Urinary tract infections. Prim Care. 2008;35(2):345-67, viidoi: 10.1016/j.pop.2008.01.001.
Drekonja, D. M., & Johnson, J. R. (2008). Urinary tract infections. Primary care, 35(2), 345-67, vii. https://doi.org/10.1016/j.pop.2008.01.001
Drekonja, Dimitri M, and Johnson, James R. "Urinary tract infections." Primary care vol. 35,2 (2008): 345-67, vii. doi: https://doi.org/10.1016/j.pop.2008.01.001
Drekonja DM, Johnson JR. Urinary tract infections. Prim Care. 2008 Jun;35(2):345-67, vii. doi: 10.1016/j.pop.2008.01.001. PMID: 18486719.
Copy Download .nbib Format: NLM
Share it on

Prim Care. 2008 Jun;35(2):345-67, vii. doi: 10.1016/j.pop.2008.01.001.

Urinary tract infections.

Primary care

Dimitri M Drekonja, James R Johnson

Affiliations

  1. Minneapolis Veterans Affairs Medical Center, Infectious Diseases (111F), 1 Veterans Drive, Minneapolis, MN 55417, USA. [email protected]

PMID: 18486719 DOI: 10.1016/j.pop.2008.01.001

Abstract

Urinary tract infection (UTI), with its diverse clinical syndromes and affected host groups, remains one of the most common but widely misunderstood and challenging infectious diseases encountered in clinical practice. Antimicrobial resistance is a leading concern, with few oral options available to treat infections caused by Gram-negative organisms resistant to trimethoprim-sulfamethoxazole and fluoroquinolones, especially for patients with upper tract disease. Efforts should be made not to detect or treat asymptomatic bacteriuria and funguria; to ensure an appropriate duration of therapy for symptomatic infections; and to limit the use of broad-spectrum agents, especially fluoroquinolones, if narrower spectrum agents are available. Further research is needed regarding rapid diagnosis of UTI, accurate presumptive identification of patients with resistant pathogens, and development of new antimicrobials for drug-resistant UTI.

MeSH terms

Publication Types